38 Stocks Moving In Monday's Mid-Day Session



  • Society Pass Incorporated SOPA shares jumped 120.9% to $7.31 after the company reported addition to the Russell 2000 Index.
  • Can-Fite BioPharma Ltd. CANF gained 74.4% to $2.2150 after the company announced a liver cancer patient was cleared of all cancer lesions.
  • Bluerock Residential Growth REIT, Inc. BRG jumped 70.2% to $26.28. Blackstone agreed to buy Bluerock Residential Growth REIT in a deal valued at $3.6 billion, extending its push into U.S. rental housing.
  • Galera Therapeutics, Inc. GRTX gained 37.5% to $4.07. Citigroup maintained Galera Therapeutics with a Buy and raised the price target from $11 to $20.
  • Verso Corporation VRS shares climbed 34.4% to $26.94 after the company announced it would be acquired by BillerundKorsnas for $27 per share.
  • CooTek (Cayman) Inc. CTK gained 27% to $0.6348 after the company announced its Fengdu Novel reached a collaboration with Tencent Video's Mars Project.
  • Intra-Cellular Therapies, Inc. ITCI gained 22.3% to $47.89 after the company's Caplyta was approved by the FDA for bipolar depression.
  • Roivant Sciences Ltd. ROIV jumped 22.3% to $13.40 after gaining 18% on Friday.
  • Quotient Limited QTNT gained 19% to $2.69. Quotient recently won a $77 million Defense Logistics Agency contract.
  • StarTek, Inc. SRT jumped 17% to $4.61.
  • Fortuna Silver Mines Inc. FSM surged 16.9% to $3.7650 after the company announced the SEMARNAT granted a twelve year extension of the environmental impact authorization at the San Jose Mine, located in Oaxaca, Mexico.
  • BP Midstream Partners LP BPMP jumped 12.7% to $14.55. BP announced agreement to acquire remaining stake in BP Midstream Partners, Reuters reported.
  • Lineage Cell Therapeutics, Inc. LCTX gained 12.5% to $2.3850 after the company announced it established a worldwide collaboration with Genentech for the development and commercialization of OpRegen RPE cell therapy for the treatment of ocular disorders.
  • Vinco Ventures, Inc. BBIG jumped 12.5% to $3.46.
  • GBS Inc. GBS rose 11.1% to $1.40 after dipping 23% on Friday. GBS recently announced application for FDA breakthrough device designation to fast track rapid saliva glucose test.
  • Calliditas Therapeutics AB CALT rose 10.8% to $26.01 after HC Wainwright & Co maintained a Buy rating on the stock and raised its price target from $52 to $62. Calliditas Therapeutics recently announced it was granted by the FDA accelerated approval of TARPEYO to reduce proteinuria in lgA nephropathy.
  • Limelight Networks, Inc. LLNW gained 10.2% to $3.57. Raymond James upgraded Limelight Networks from Market Perform to Strong Buy.
  • KemPharm, Inc. KMPH surged 9.7% to $8.54 as the company reported authorization of $50 million buyback.
  • argenx SE ARGX gained 8.9% to $337.42 after the company announced the FDA approved VYVGART for the treatment of generalized myasthenia gravis in adult patients who are anti-acetylcholine receptor antibody positive.
  • Asana, Inc. ASAN jumped 7.2% to $80.14.

Check out these big penny stock gainers and losers


  • Summit Therapeutics Inc. SMMT shares dipped 46.4% to $2.67 after reporting topline results for Phase III Ri-CoDIFy study for C. Difficile infection. The company said Ri-CoDIFy did not meet primary endpoint.
  • Spruce Biosciences, Inc. SPRB fell 26.9% to $3.6785. Spruce Biosciences shares jumped more than 102% on Friday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $15 price target.
  • Bellerophon Therapeutics, Inc. BLPH fell 23.3% to $2.45. Bellerophon Therapeutics jumped around 35% on Friday after topline data from Phase 2 study (PULSE-PHPF-002) evaluating the acute hemodynamic benefit of INOpulse via right heart catheterization for pulmonary hypertension associated with sarcoidosis (PH-Sarc)..
  • bluebird bio, Inc. BLUE dropped 20.7% to $8.41. The FDA placed a partial clinical hold on Bluebird bio’s lovotibeglogene autotemcel (lovo-cel) gene therapy program for sickle cell disease (SCD) for patients under the age of 18.
  • Optical Cable Corporation OCC dipped 18.9% to $5.22 after the company reported Q4 earnings results.
  • Immix Biopharma, Inc. IMMX fell 14.6% to $3.4150 amid post-IPO volatility.
  • Clarus Therapeutics Holdings, Inc. CRXT dropped 13.7% to $3.1850.
  • Ipsidy Inc. AUID dipped 13.6% to $14.45.
  • Stronghold Digital Mining, Inc. SDIG dropped 13.1% to $10.94. Stronghold Digital Mining said it acquired 9,080 bitcoin miners and secured $54 million equipment financing.
  • ForgeRock, Inc. FORG fell 12.4% to $22.15. The company recently disclosed two significant new features to the ForgeRock Identity Cloud called Organizations and Themed User Journeys.
  • Zhihu Inc. ZH shares fell 11.5% to $5.06. China summoned Zhihu for unlawful release of information.
  • California Resources Corporation CRC dipped 11.3% to $37.60.
  • Argo Blockchain plc ARBK fell 11.1% to $11.53 after rising around 5% on Friday.
  • Sono Group N.V. SEV dropped 10.2% to $10.19.
  • Tuya Inc. TUYA fell 9.6% to $5.90.
  • Eloxx Pharmaceuticals, Inc. ELOX shares fell 9.3% to $0.6701. Eloxx Pharmaceuticals shares climbed 12% on Friday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $4 price target.
  • Turkcell Iletisim Hizmetleri A.S. TKC fell 9.2% to $3.06 after declining around 6% on Friday.
  • Arqit Quantum Inc. ARQQ shares fell 8.3% to $18.27 after jumping 22% on Friday.
Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapIntraday UpdateMarketsMoversTrading IdeasInformation TechnologyInternet Software & ServicesMid-Day MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!